Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(6.0%),Lind Global Partners II LLC(6.0%), etc.
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SEMBER MICHAEL T
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Dunn Gordon
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Myers Michael
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Culverwell Anthony James
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cooper Joseph Patrick
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Leong Natalie Ee Mun
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Carter Denise P.
Quoin Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director LANGER DENNIS
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director SEMBER MICHAEL T
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director LANGER DENNIS
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director Cooper Joseph Patrick
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director Culverwell Anthony James
Quoin Pharmaceuticals | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Director Leong Natalie Ee Mun
Quoin Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(0.0 %),GOLDMAN SACHS & CO. LLC(0.0 %)
Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(4.9%),Heights Capital Management, Inc.(4.9%)
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Myers Michael
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Cooper Joseph Patrick
Quoin Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer Carter Denise P.
No Data